Nelson Bunker Curnes Purchases 5,000 Shares of Mobia Medical (NASDAQ:MOBI) Stock

Mobia Medical, Inc. (NASDAQ:MOBI) CFO Nelson Bunker Curnes bought 5,000 shares of the stock in a transaction dated Tuesday, June 9th. The shares were bought at an average cost of $12.79 per share, with a total value of $63,950.00. Following the completion of the purchase, the chief financial officer directly owned 366,997 shares of the company’s stock, valued at approximately $4,693,891.63. This trade represents a 1.38% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Mobia Medical Stock Down 0.1%

Shares of MOBI opened at $12.31 on Friday. The firm has a market cap of $409.30 million, a PE ratio of 66.00 and a beta of 2.84. Mobia Medical, Inc. has a 12-month low of $10.19 and a 12-month high of $14.77.

Mobia Medical (NASDAQ:MOBI) last issued its earnings results on Thursday, June 4th. The company reported $999.00 earnings per share (EPS) for the quarter. The company had revenue of $12.07 million for the quarter.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They set an “overweight” rating and a $15.00 target price for the company. Zacks Research raised shares of Mobia Medical to a “hold” rating in a research note on Wednesday, June 3rd. BTIG Research assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They set a “buy” rating and a $19.00 target price for the company. Wolfe Research assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They issued an “outperform” rating for the company. Finally, Wall Street Zen lowered shares of Mobia Medical from a “hold” rating to a “sell” rating in a research note on Saturday, June 6th. Five investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, Mobia Medical presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.25.